In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Deferiprone Drug Master File in Korea (Deferiprone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Deferiprone. The MFDS reviews the Deferiprone KDMF as part of the drug registration process and uses the information provided in the Deferiprone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Deferiprone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Deferiprone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Deferiprone suppliers with KDMF on PharmaCompass.